FDA Approved: VECTIBIX — Supplemental Application (Amgen, Inc)

View source ↗

Summary

FDA approved a supplemental application for VECTIBIX (panitumumab) by Amgen, Inc., resulting in updates to the product labeling and/or indications.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Colorectal Cancer

Drugs mentioned

• Vectibix (panitumumab)

Snippet

SUPPL AP for VECTIBIX (PANITUMUMAB)